📰 1 source covering this story

Pro-life CEO predicts Trump FDA nominee could bring renewed scrutiny to abortion drug risks

Compare how each outlet is covering it — and rate the sources you trust.

Pro-life CEO predicts Trump FDA nominee could bring renewed scrutiny to abortion drug risks
Fox News
Fox News45 mins ago
Pro-life CEO predicts Trump FDA nominee could bring renewed scrutiny to abortion drug risks
Trump's FDA nominee Heidi Overton could bring renewed scrutiny to mifepristone, says Americans United for Life CEO who calls her a "pro-life" pick.
Top rated outlets
Outlets are ranked once they have 3+ community ratings — be one of the first to rate.
🏆 Most trusted sources 2026 →
Scores come entirely from reader ratings — rate the sources you read to shape them. How it works →